Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data from lung adenocarcinoma

ABSTRACT: Affymetrix Human Genome U133A platform was used to obtain gene expression profiles of 28 pathologically and clinically well characterized adenocarcinomas of the lung. In addition, EGFR status was determined by fluorescent in situ hybridization and immunohistochemistry. The classification of the cases using a clustering algorithm applied to the expression data correlated significantly with the histopathological tumor grades. In contrast, no correlation of gene expression data and EGFR status could be detected.

ORGANISM(S): Homo sapiens

PROVIDER: GSE17475 | GEO | 2009/08/04

SECONDARY ACCESSION(S): PRJNA118705

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Expression data from lung adenocarcinoma

Project description:Affymetrix Human Genome U133A platform was used to obtain gene expression profiles of 28 pathologically and clinically well characterized adenocarcinomas of the lung. In addition, EGFR status was determined by fluorescent in situ hybridization and immunohistochemistry. The classification of the cases using a clustering algorithm applied to the expression data correlated significantly with the histopathological tumor grades. In contrast, no correlation of gene expression data and EGFR status could be detected. In this study we evaluated the gene expression of 28 clinico-pathological well characterized lung adenocarcinomas.

2009-08-04 | E-GEOD-17475 | biostudies-arrayexpress

Differential gene expression in astrocytic tumours

Project description:This study aims at investigating differential gene expression in human astrocytic tumours of grades I, II, III and IV. A total of 65 tumours were assessed using the Affymetrix U133A GeneChip. The study aims not only at discovering the main expression differences between astrocytic tumours of distinct histological grades but also wishes to correlate these findings with the known histopathological hallmarks of astrocytoma progression. Further, the study aims at correlating gene expression with previously obtained genomic information for several loci known to be involved in astrocytoma tumour progression. Keywords: other

2007-05-26 | GSE1993 | GEO

MSKCC-A Primary Lung Cancer Specimens

Project description:Develop an EGFR mutation gene expression signature to aid in predicting response and clinical outcome and to identify genes associated with the EGFR-dependent phenotype 30 primary lung adenocarcinomas and 20 adjacent normal lung controls were analyzed with Affymetrix U133A

2011-09-05 | E-GEOD-31547 | biostudies-arrayexpress

Transcription profiling of human astrocytic tumours of grades I, II, III and IV

2008-06-12 | E-GEOD-1993 | biostudies-arrayexpress

Transcription profiling of human diffusely infiltrating astrocytic tumours, grades II, III and IV

Project description:This study aims at investigating differential gene expression in human diffusely infiltrating astrocytic tumours, grades II, III and IV. A total of 63 tumours were assessed using the Affymetrix U133A GeneChip. Samples comprised in this GEO submission are identical to those in submission GSE1993 with the exception of two pilocytic astrocytoma tumours (grade I) that have not been included. The study aims not only at discovering the main expression differences between astrocytic tumours of distinct histological grades but also wishes to correlate these findings with the known histopathological and biological hallmarks of astrocytoma progression. Further, the study aims at correlating gene expression with previously obtained genomic information for several loci known to be involved in astrocytoma tumour progression. Experiment Overall Design: A total of 63 tumours were assessed using the Affymetrix U133A GeneChip.

2008-06-12 | E-GEOD-2727 | biostudies-arrayexpress

Differential gene expression in diffusely infiltrating astrocytic

2007-05-26 | GSE2727 | GEO

Involuted normal mammary gland in WAP-SV40 transgenic mice [gene expression]

Project description:Transgenic expression in mice of two synergistically acting SV40 early region encoded proteins, large (LT) and small (sT) tumor antigens, in the mammary epithelium recapitulates loss of p53 and Rb function and deregulation of PP2A-controlled mitogenic pathways in human breast cancer. In primiparous mice, WAP-promoter driven expression of SV40 proteins induces well and poorly differentiated mammary adenocarcinomas. We performed a correlative aCGH and gene expression analysis of 25 monofocal tumors, representing four histopathological grades, to explore the molecular traits of SV40-induced mammary tumors and to emphasize the relevance of this tumor model for human breast tumorigenesis.

2012-10-31 | GSE33038 | GEO

Mammary carcinomas in WAP-SV40 transgenic mice [gene expression]

2012-10-31 | GSE29117 | GEO